For many women, an OB-GYN clinician is the physician they see most often. Women often visit their OB-GYN during vulnerable periods of life, including adolescence, pregnancy, postpartum and the menopausal transition, which can trigger bouts of depression or anxiety. The integration of behavioral health and women’s health care has become more common as OB-GYNs encounter […]
Acadia (NASDAQ: ACHC) is prioritizing strategic investment in its technology capabilities and comprehensive treatment centers (CTCs) for opioid use disorder. At the JP Morgan Healthcare Conference, Acadia CEO Christopher Hunter said these priorities would “drive the business forward” over the next year. As the largest pure-play behavioral health provider, Acadia sets the tone for the […]
Medications like methadone and buprenorphine have become the gold standard for treating opioid use disorder (OUD). But many people with OUD still receive abstinence-based treatment or no treatment at all for the chronic disorder. And people with OUD who receive abstinence-only treatment are more likely to die than people who receive no treatment at all, […]
After a tumultuous 2023, 2024 may be a steadier year for the behavioral health industry. While behavioral health deals slipped in 2023, Behavioral Health Business expects M&A to pick up this year as interest rates fall and the economy stabilizes. Still, the M&A craze of 2021 is unlikely, and mega deals will be scarce. This […]
Despite an “urgent” need for Medicare beneficiaries to receive treatment for opioid use disorder (OUD), a low percentage receive potentially life-saving medication-assisted treatment (MAT) for the condition. Approximately 52,000 Medicare enrollees experienced an opioid overdose in 2022, according to a report from the Office of Inspector General (OIG). However, only 18% of Medicare patients with […]
Despite the strong growth potential in the substance use disorder (SUD) treatment space, providers faced stiff headwinds in 2023, including rising patient acuity, access obstacles and shifting regulatory frameworks. Some of these challenges will continue to present problems for SUD treatment providers in 2024, but the new year will also bring significant opportunities, industry insiders […]
Katherine Truesdell started using meth and alcohol when she was in middle school. As an adult, she hit “rock bottom” when child protective services got involved with her children, pushing her towards sobriety. Now, Truesdell is in long-term recovery and works as a peer specialist in Elevance Health’s (NYSE: ELV) Empower program. The program, launched […]
Landmark Recovery has been evicted from two facilities in different states, bringing the total of facilities lost to forced closures in 2023 to five. Public documents and other sources show that the Franklin, Tennessee-based addiction treatment facility operator struggled with several financial obligations after the sudden closure of three Indiana facilities. After charting a high-flying […]
Opioid overdose reversal medicines like Narcan may soon be as standard-issue as fire extinguishers in affordable and public housing communities. The federal government urged housing providers to stock drugs like Narcan onsite in a joint letter signed by the White House Office of National Drug Control Policy, the Department of Health and Human Services (HHS), […]
The newly released fourth edition criteria from the American Society of Addiction Medicine (ASAM) has a renewed focus on holistic and patient-centered care for treating substance use disorders (SUD). Some of the main topics included a focus on chronic care treatment, integrated care, treating co-occurring conditions, recovery support services and harm reduction models. ASAM is […]
By continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
